Sharekhan

Suraksha Diagnostic Ltd

Fri 15/05/2026,15:50:20 | NSE : SURAKSHA

₹ 305.751.70 (0.56%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 300.15

Previous Close

₹ 304.05

Volume

13234

Mkt Cap ( Rs. Cr)

₹1592.37

High

₹ 307.00

Low

₹ 299.00

52 Week High

₹ 352.50

52 Week Low

₹ 224.10

Book Value Per Share

₹ 45.63

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Suraksha Diagnostic Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

305.75

4

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

4

Option Chain

Analyzes market sentiment, predicts Suraksha Diagnostic Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    15 May 2026, 4:32PM Intimation of the schedule of Analysts/Institutional Investors/ Organisations meeting to be held on Friday, 22 May 2026 at 12:00 P.M. (IST).
  • Suraksha Diagnostic - Board Meeting Intimation for Inter-Alia, Considering And Approving Audited (Standalone And Consolidated

    13 May 2026, 6:00PM Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider
  • Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations

    4 May 2026, 10:47PM ÿDr. Somnath Chatterjeeÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Subst
  • Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations

    4 May 2026, 2:48PM Dr. Somnath Chatterjeeÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa
  • Suraksha Diagnostic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    6 Apr 2026, 5:08PM Suraksha Diagnostic Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Suraksha Diagnostic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Apr 2026, 4:58PM Please find enclosed the Certificate received under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 from M/s. KFin Technolo
  • Suraksha Diagnostic has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    4 Apr 2026, 3:40PM As of March 2026, 49.10% is owned by Indian Promoters and 50.90% by Public. <p align=justify> Top five Promoters holding highest number of shares of S
  • Suraksha Diagnostic - Trading Window

    20 Mar 2026, 12:49PM Suraksha Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Mar 2026, 1:22PM Suraksha Diagnostic Limited has informed the Exchange about schedule of the Analysts/ Institutional Investors/ Organisations meeting
  • Suraksha Diagnostic - Resignation

    2 Mar 2026, 12:22PM Suraksha Diagnostic Limited has informed the Exchange regarding Resignation of Mr K S Ravindra as Group Chief Financial Officer (CFO), designated as K
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    2 Mar 2026, 1:17PM Intimation of the schedule of Analysts/ Institutional Investors/ Organisations meeting to be held on Monday, 09 March 2026 at 10:00 am
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    2 Mar 2026, 12:09PM Intimation of resignation of Mr. K S Ravindra, Group Chief Financial Officer (CFO), designated as Key Managerial Personnel (KMP) of the Company

Key fundamentals

Evaluate the intrinsic value of Suraksha Diagnostic Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 220.1374 189.5015 170.6301 169.0335
Liabilities 220.1374 189.5015 170.6301 169.0335
Equity 10.4162 6.9 6.9 6.9
Gross Profit 82.5903 71.1917 44.9867 47.5072
Net Profit 33.44 24.3839 7.189 23.751
Cash From Operating Activities 62.798 61.23 44.9253 42.3306
NPM(%) 13.42 11.15 3.78 10.64
Revenue 249.0954 218.5247 189.9854 223.1925
Expenses 166.5051 147.333 144.9987 175.6853
ROE(%) 14.07 10.26 3.02 9.99

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Suraksha Diagnostic Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 720.85 2.41 0.00 174.64 -26.19 0.69
Lotus Eye Hospital and Institute Ltd 106.56 -4.06 343.74 636.37 3.55 0.00
Vaishali Pharma Ltd 7.07 1.73 0.00 3992.14 3.13 0.00
Astec Lifesciences Ltd 675.80 2.83 0.00 600.11 -363.15 0.00

Company Info

The Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of Rs.300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of Rs.200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs.30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs.67 million.2023-Established our first 3T MRI and 128 CT at New Town

The Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of Rs.300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of Rs.200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs.30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs.67 million.2023-Established our first 3T MRI and 128 CT at New Town

Read More

Parent Organisation

Suraksha Diagnostic Ltd.

Founded

15/03/2005

Managing Director

Ms.Ritu Mittal

NSE Symbol

SURAKSHAEQ

FAQ

The current price of Suraksha Diagnostic Ltd is ₹ 305.75.

The 52-week high for Suraksha Diagnostic Ltd is ₹ 307.00 and the 52-week low is ₹ 299.00.

The market capitalization of Suraksha Diagnostic Ltd is currently ₹ 1592.37. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Suraksha Diagnostic Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Suraksha Diagnostic Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Suraksha Diagnostic Ltd shares.

The CEO of Suraksha Diagnostic Ltd is Ms.Ritu Mittal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT